Horizon Pharmaceutical Overview
- Status
-
Acquired/Merged
- Employees
-
182
- Latest Deal Type
-
M&A
- Financing Rounds
-
5
- Investments
-
7
Horizon Pharmaceutical General Information
Description
Provider of bio-pharmaceutical therapies intended to treat diseases that are debilitating and life-threatening. The company's bio-pharmaceutical therapies focuses on developing and commercializing therapies to treat debilitating and often fatal diseases for Huntington's disease, non-fatty liver disease, primary liver cancer & other cancers.
Contact Information
Website
www.raptorpharma.comCorporate Office
- 7 Hamilton Landing
- Suite 100
- Novato, CA 94949
- United States
Corporate Office
- 7 Hamilton Landing
- Suite 100
- Novato, CA 94949
- United States
Horizon Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Horizon Pharmaceutical Comparisons
Industry
Financing
Details
Horizon Pharmaceutical Competitors (137)
One of Horizon Pharmaceutical’s 137 competitors is Sarepta Therapeutics, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sarepta Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Bristol-Myers Squibb | Corporation | Princeton, NJ | ||||
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA | ||||
| uniQure | Formerly VC-backed | Amsterdam, Netherlands | ||||
| Taysha Gene Therapies | Formerly VC-backed | Dallas, TX |
Horizon Pharmaceutical Signals
Horizon Pharmaceutical Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Horizon Pharmaceutical Investments & Acquisitions (7)
Horizon Pharmaceutical’s most recent deal was a Merger/Acquisition with Quinsair for . The deal was made on 05-Oct-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Quinsair | 05-Oct-2015 | Merger/Acquisition | Pharmaceuticals | ||
| TorreyPines Therapeutics | 28-Sep-2009 | Merger/Acquisition | Drug Discovery | ||
| Convivia (ALDH2 deficiency product) | 21-Apr-2008 | Merger/Acquisition | Buildings and Property | ||
| University of California, San Diego (worldwide license to intellectual property of Cysteamine) | 19-Mar-2008 | Corporate Asset Purchase | Buildings and Property | ||
| CalciMedica | 23-Jan-2008 | Early Stage VC | Drug Discovery |
Horizon Pharmaceutical Exits (2)
Horizon Pharmaceutical’s most recent exit was on 23-Jan-2008 from CalciMedica. The exit was categorized as with 3 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| CalciMedica | 23-Jan-2008 | Completed |
|
||
| CalciMedica | 20-Jul-2007 | Early Stage VC | Completed |
|
Horizon Pharmaceutical FAQs
-
Where is Horizon Pharmaceutical headquartered?
Horizon Pharmaceutical is headquartered in Novato, CA.
-
What is the size of Horizon Pharmaceutical?
Horizon Pharmaceutical has 182 total employees.
-
What industry is Horizon Pharmaceutical in?
Horizon Pharmaceutical’s primary industry is Drug Discovery.
-
Is Horizon Pharmaceutical a private or public company?
Horizon Pharmaceutical is a Private company.
-
What is the current valuation of Horizon Pharmaceutical?
The current valuation of Horizon Pharmaceutical is .
-
What is Horizon Pharmaceutical’s current revenue?
The current revenue for Horizon Pharmaceutical is .
-
How much funding has Horizon Pharmaceutical raised over time?
Horizon Pharmaceutical has raised $17.1M.
-
Who are Horizon Pharmaceutical’s investors?
Great Point Partners, Heights Capital, Patricia Industries, RiverVest Venture Partners, and Synthesis Capital (Boston) have invested in Horizon Pharmaceutical.
-
Who are Horizon Pharmaceutical’s competitors?
Sarepta Therapeutics, Bristol-Myers Squibb, Sangamo Therapeutics, uniQure, and Taysha Gene Therapies are some of the 137 competitors of Horizon Pharmaceutical.
-
When was Horizon Pharmaceutical acquired?
Horizon Pharmaceutical was acquired on 25-Oct-2016.
-
Who acquired Horizon Pharmaceutical?
Horizon Pharmaceutical was acquired by Horizon Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process